Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Mebendazole ingredients?
Diltiazem drug class?
How long have hydroxyzine pamoate been on the market?
Combivent generic equivalent?
What is the difference between apixaban and apixaban accord?

Fda approval acalabrutinib date?

See the DrugPatentWatch profile for acalabrutinib

The FDA approved acalabrutinib (Calquence) for the first time on February 28, 2017, for adults with mantle cell lymphoma (MCL). If you need the approval dates for other indications (e.g., CLL/SLL or GVHD), I can provide those as well.



Other Questions About Acalabrutinib :

acalabrutinib cost Acalabrutinib 100 mg? Acalabrutinib fda approval cll? Acalabrutinib approval date fda? Acalabrutinib fda approval? Acalabrutinib first fda approval date? Acalabrutinib approval date?